Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

Por Toyos, Melissa M.
Publicado no Ophthalmol Ther (2019)

Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study

Por Sheppard, John D., Toyos, Melissa M., Kempen, John H., Kaur, Paramjit, Foster, C. Stephen
Publicado no Invest Ophthalmol Vis Sci (2014)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Por Tauber, Joseph, Schechter, Barry A, Bacharach, Jason, Toyos, Melissa M, Smyth-Medina, Robert, Weiss, Sidney L, Luchs, Jodi I
Publicado no Clin Ophthalmol (2018)

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial

Por Nichols, Kelly K, Holland, Edward, Toyos, Melissa M, Peace, James H, Majmudar, Parag, Raychaudhuri, Aparna, Hamdani, Mohamed, Roy, Monica, Shojaei, Amir
Publicado no Clin Ophthalmol (2018)